1. Home
  2. ELEV vs LIVE Comparison

ELEV vs LIVE Comparison

Compare ELEV & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • LIVE
  • Stock Information
  • Founded
  • ELEV 2019
  • LIVE 1968
  • Country
  • ELEV United States
  • LIVE United States
  • Employees
  • ELEV N/A
  • LIVE N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • LIVE Other Specialty Stores
  • Sector
  • ELEV Health Care
  • LIVE Consumer Discretionary
  • Exchange
  • ELEV Nasdaq
  • LIVE Nasdaq
  • Market Cap
  • ELEV 22.0M
  • LIVE 26.6M
  • IPO Year
  • ELEV 2021
  • LIVE N/A
  • Fundamental
  • Price
  • ELEV $0.36
  • LIVE $21.72
  • Analyst Decision
  • ELEV Buy
  • LIVE
  • Analyst Count
  • ELEV 6
  • LIVE 0
  • Target Price
  • ELEV $2.94
  • LIVE N/A
  • AVG Volume (30 Days)
  • ELEV 996.3K
  • LIVE 27.2K
  • Earning Date
  • ELEV 05-16-2025
  • LIVE 05-08-2025
  • Dividend Yield
  • ELEV N/A
  • LIVE N/A
  • EPS Growth
  • ELEV N/A
  • LIVE N/A
  • EPS
  • ELEV N/A
  • LIVE N/A
  • Revenue
  • ELEV N/A
  • LIVE $455,142,000.00
  • Revenue This Year
  • ELEV N/A
  • LIVE N/A
  • Revenue Next Year
  • ELEV N/A
  • LIVE N/A
  • P/E Ratio
  • ELEV N/A
  • LIVE N/A
  • Revenue Growth
  • ELEV N/A
  • LIVE 5.53
  • 52 Week Low
  • ELEV $0.22
  • LIVE $6.25
  • 52 Week High
  • ELEV $4.33
  • LIVE $26.23
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 52.69
  • LIVE 90.57
  • Support Level
  • ELEV $0.34
  • LIVE $11.12
  • Resistance Level
  • ELEV $0.36
  • LIVE $11.69
  • Average True Range (ATR)
  • ELEV 0.03
  • LIVE 1.37
  • MACD
  • ELEV 0.00
  • LIVE 0.78
  • Stochastic Oscillator
  • ELEV 50.00
  • LIVE 100.00

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

Share on Social Networks: